First Patient Dosing Commences of HER-Vaxx
Filed with ASX · · 3 pages · English
Story so far
Earlier from Imugene
- Imugene granted Canadian patent for Her-Vaxx cancer vaccine
- Appendix 4C - quarterly and Commentry Q3
- IMU Raises $3.0m from Options Plan
- $1.35 million Options Underwritten
- Half Year Report and Accounts
Later from Imugene
- IMU Receives $1.1m R&D Tax Refund
- Response to ASX Price Query
- Imugene raises $8.7 million
- Rights Issue Results & Shortfall Notification
- Business Update - December Quarter Appendix 4C
Follow Imugene into a list and get an email when it puts out news.
Follow Imugene